[Antimycobacterial acting carbazole derivatives]

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Microbiology

Context:

• Tuberculosis remains a significant global health challenge, necessitating the development of novel therapeutic agents.
• Carbazole derivatives have emerged as a potential scaffold for antimycobacterial drug discovery.
• Understanding structure-activity relationships is crucial for optimizing drug candidates.

Purpose:

• To synthesize novel carbazole derivatives and evaluate their antimycobacterial properties against Mycobacterium tuberculosis.
• To investigate the influence of stereochemistry (diastereomers and enantiomers) on antimycobacterial activity.
• To explore enantioselective synthesis strategies for potent carbazole analogs.

Summary:

• A series of carbazole compounds were synthesized and screened for their inhibitory effects on Mycobacterium tuberculosis (H 37 Ra strain) in Middlebrook-7H9 broth.
• Compounds 32 and 33 were assessed to understand the differential activity of diastereomers.
• The antimycobacterial efficacy of a racemic mixture and its corresponding (+)-enantiomer were compared for compounds 12 and 5.
• Compound (+)-12 was successfully prepared via an enantioselective synthetic route.

Impact:

• This study provides valuable insights into the carbazole scaffold's potential as a source of new anti-tuberculosis drugs.
• The findings highlight the importance of stereochemistry in dictating antimycobacterial potency, guiding future drug design efforts.
• The development of enantioselective synthesis methods facilitates the production of stereochemically pure compounds for further investigation.